Volume : 12, Issue : 04, April – 2025

Title:

FORMULATION AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF SIMVASTATIN

Authors :

Dr. Nallamolu Bala Venkata Siva Ram *, Mandapati Jaswanth Kumar, Potla Rahul, Davuluri Onika

Abstract :

In the present research work, we have designed a pulsatile formulation of Simvastatin to treat dyslipidemia pattern of the disease. Core tablets were prepared by incorporating different concentration of disintegrants and were compressed in between different concentration of polymers. The core and compression coated tablets were subjected to pre-formulation, physicochemical and In-vitro drug release studies. Core formulations, characterized by different release rates and mechanisms, will be coated by compression with an outer shell of different polymeric barrier layers of polymers. The coatings prevent drug release from the core until the polymeric shell is completely eroded or swollen. FTIR studies revealed that there was not any chemical reaction between pure drug Simvastatin and polymers. The pre and post-compressional parameters of tablets were also found to be within limits. Our optimized formulation F-3 releases Simvastatin 100.15 % up to 12 hours.
Key words: Pulsatile formulation, Simvastatin, Sodium starch glycolate, Chitosan, Eudragit RSPO, HPMC K 100 and Compression coated tablets.

Cite This Article:

Please cite this article in press Nallamolu Bala Venkata Siva Ram et al., Formulation And Evaluation Of Pulsatile Drug Delivery System Of Simvastatin.,, Indo Am. J. P. Sci, 2025; 12(04).

Number of Downloads : 10

References:

1. Trupti Shashikant Jadhav, Nilima A. Thombre, Sanjay J. Kshirsagar. Pulsatile drug delivery system using core-in-cup approach: a review. June 2016; vol. 3 (Issue 3): 288-304.
2. Chien YW. Novel drug delivery system. 2nd ed, Marcel Decker Inc., New York; 2005: 1-3.
3. Davis SS, Illum L. Drug delivery systems for challenging molecules. Int J Pharm. 1998;176:1-8.
4. Bussemer T, Bodmeier RA. Drug delivery Pulsatile. Encyclopaedia of pharmaceutical technology; 2006: 1287-1297.
5. Bjorn L. The importance of circadian rhythms on drug response in hypertension and coronary heart diseases. Pharmacology and therapeutics. 2006;111:629-65.
6. Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery current perspective. J Controlled Rel. 2009;134:74-80.
7. Smolensky MH, Lemmer B et al. Chronobiology and chronotherapeutics of allergic rhinitis and bronchial asthma. Ame J Res Cri Care Med. 2007;59:852-82.
8. Fort J. Celecoxib, a COX-2-specific inhibitor: the clinical data. Am J Orthop. 1999;28(3):13-8.
9. Prashant AB, Bushetti SS, Najmuddin M. Formulation and evaluation of pulsatile drug delivery system of Metoprolol tartarate using core in cup tablet. Am J Med Med Sci. 2012;2(6):114-22.
10. Gao W, Zhonghong WU, Chen Q, Bin YU. Preparation of Candesartan celexitil core in cup tablets with pulsatile release properties and its effects on the blood pressure of rabbits. J China Pharm Uni. 2010;41(2):124- 9.
11. Khadabadi SS, Nahid HC, Farhan MK, Akeel AT. Formulation and evaluation of press coated tablet of ketoprofen- a chronotherapeutic approach. Int J Pharm Pharm Sci. 2012;5(3):733-40.
12. Li CJ, Zhu JB, Yu WY. Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release. 2008;43(6):652-6.
13. Archana SP, Panchaxari MD, Vinayak SM, Anand PG, Basavaraj KN. Development and characterization of chronomodulated drug delivery system of captopril. Int J Pharm Inv. 2011;1(4):227-33.
14. Rane AB, Gattani SG, Kadam VD, Tekade AR. Formulation and evaluation of press coated tablets for pulsatile drug delivery using hydrophilic and hydrophobic polymers. Chem Pharm Bull (Tokyo). 2009;57(11):1213-7.
15. Swati J, Monali S, Ajay B, Janardan L, Bhanudas K, Anuruddha C. Development of pulsatile release tablets of atenolol with swelling and rupturable layers. Int J Pharm. 2010;2(3):31-40.
16. Rane AB, Gattani SG, Kadam VD, Tekade AR. Formulation and evaluation of press coated tablets for pulsatile drug delivery using hydrophilic and hydrophobic polymers. Chem Pharm Bull (Tokyo). 2009;57(11):1213-7.
17. Mastiholimath VS, Dandagi PM, Samata SJ, Gadad AP, Kulkarni AR. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma, Int journal pharma. 2007;328: 49-56.
18. Narisawa S, Nagata M, Danyoshi C, Yoshino H, Murata K, Hirakawa Y, et al. An organic acid induced sigmoidal release system for oral controlled-release preparations. Pharma Research. 1994;11(1):111-6.
19. Ramesh d,parmar, rajesh k,parikh,g.vidyasagar,dhaval. Pulsatile drug delivery systems. International journal of pharmaceutical sciences and nanotechnology 2009:3:605-611.
20. Yui n, okano t and sakurai y. In flammation responsive degradation of cross linked hyaluronic acid gels. Journal of controlled release 1992;22:105-116.
21. Donthireddy Sushma. Formulation and Evaluation of Press Coated Tablets for Pulsatile Drug Delivery. J Biomed Syst Emerg Technol, Volume 8:5, 2021.
22. A Vijaya Madhavi, D Rama Brahma Reddy, M Venugopal, N Srihari, P Chenniah, P Koteswarao. Formulation and Evaluation of Pulsatile Drug Delivery System of Zafirlukast. Journal of Drug Delivery & Therapeutics. 2020; 10(2):122-128.
23. B. Manjula, V. Divyasri, Ch. Shravya, Ch. Maniteja Yadav, Ch. Soujanya. Formulation and Evaluation of Pulsatile Drug Delivery System of Lisinopril. Journal of Drug Delivery & Therapeutics. 2019; 9(2):76-82.
24. Manish Kumar Gupta, Swarnlata Saraf. Formulation and Evaluation of Pulsatile Drug Delivery System of Ramipril for Controlling Morning Spate of B.P. Journal of Pharmaceutical Research, Volume 17, Issue 1, Jan-Mar, 2018.
25. Chiranjibi Adhikari, Gururaj S Kulkarni, Shivakumar Swamy. Formulation And Evaluation Of Pulsatile Drug Delivery System Of Salbutamol Sulfate For The Chronotherapy Of Asthma. Vol 11, Issue 9, 2018